These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A colony inhibition (CI) technique for demonstration of tumor cell destruction by lymphoid cells in vitro. Hellström I Int J Cancer; 1967 Jan; 2(1):65-8. PubMed ID: 6036067 [No Abstract] [Full Text] [Related]
5. Studies on the mechanism of isoantigenic variant formation in heterozygous mouse tumors. IV. H-2 component analysis of an (A-Sn x A.SW)F1 lymphoma. Ozer HL; Klein G; Ozer JH J Natl Cancer Inst; 1966 Feb; 36(2):233-47. PubMed ID: 5325483 [No Abstract] [Full Text] [Related]
6. Inhibition of mouse tumor cells in vitro by contact with lymph node and tumor cells containing foreign H-2 antigens. Hellström KE; Hellström I Fed Proc; 1968; 27(1):39-41. PubMed ID: 4952629 [No Abstract] [Full Text] [Related]
7. ABROGATION OF ALLOGENEIC INHIBITION BY CORTISONE. HELLSTROEM KE; HELLSTROEM I; HAUGHTON G Science; 1965 Jul; 149(3679):82-4. PubMed ID: 14300525 [TBL] [Abstract][Full Text] [Related]
8. Some reactions of cytotoxic antibodies against previously unknown mouse isoantigens. Amos B Ann N Y Acad Sci; 1965 Jun; 124(1):61-72. PubMed ID: 5215770 [No Abstract] [Full Text] [Related]
9. In vitro studies of mammalian somatic cell variation. I. Detection of H-2 phenotype in cultured mouse cell lines. CANN HM; HERZENBERG LA J Exp Med; 1963 Feb; 117(2):259-65. PubMed ID: 14018308 [TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of an isoantigenic variant from a heterozygous mouse lymphoma in culture. Papermaster BW; Herzenberg LA J Cell Physiol; 1966 Jun; 67(3):407-20. PubMed ID: 5963066 [No Abstract] [Full Text] [Related]
12. Functional interactions of viral and histocompatibility antigens at tumor cell surfaces. Schrader JW; Cunningham BA; Edelman GM Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5066-70. PubMed ID: 1108012 [TBL] [Abstract][Full Text] [Related]
13. Normal murine endogenous lymphoid factor(s) inhibiting lymphocyte functions. I. In vivo effect on allogeneic tumor growth. Fejes M; Pasqualini CD; Braun M Oncology; 1980; 37(2):96-100. PubMed ID: 6444707 [TBL] [Abstract][Full Text] [Related]
14. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2). Mills GB; Paetkau V J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395 [TBL] [Abstract][Full Text] [Related]
15. Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines. Garrido F; Festenstein H; Schirrmacher V Nature; 1976 Jun; 261(5562):705-7. PubMed ID: 947087 [No Abstract] [Full Text] [Related]
16. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor. Zaleski M Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866 [TBL] [Abstract][Full Text] [Related]
17. Development of tumor lines with decreased sensitivity to allogeneic inhibition. Hellström KE Exp Cell Res; 1966 Apr; 42(1):189-92. PubMed ID: 5929565 [No Abstract] [Full Text] [Related]
18. The immunogenic and tumorigenic properties of a murine lymphoma that expresses foreign alloantigens: role of helper factor(s) in generating a cytotoxic response in vitro. Scott JW; Finke JH Transplant Proc; 1981 Dec; 13(4):1867-73. PubMed ID: 6800082 [No Abstract] [Full Text] [Related]
19. Establishment, characterization and virus expression of cell lines derived from radiation- and virus-induced lymphomas of C57BL/Ka mice. Lieberman M; Declève A; Ricciardi-Castagnoli P; Boniver J; Finn OJ; Kaplan HS Int J Cancer; 1979 Aug; 24(2):168-77. PubMed ID: 90660 [TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin isoantigens (allotypes) in the mouse. II. Allotypic analysis of three gammaG2-myeloma proteins from (NZB x BALB/c)F1 hybrids and of normal gammaG2-globulins. Warner NL; Herzenberg LA; Goldstein G J Exp Med; 1966 Apr; 123(4):707-21. PubMed ID: 4160400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]